Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Agalliu, Ilir ^a   Wang, Zhaoming ^b   Wang, Tao ^a   Dunn, Anne ^a   Parikh, Hemang ^b   Myers, Timothy ^b   Burk, Robert D ^a   Amundadottir, Laufey ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; ASHKENAZI; BREAST CANCER; CANCER FAMILY; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROGENY; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AREA UNDER CURVE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JEWS; MALE; MIDDLE AGED; ODDS RATIO; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK; ROC CURVE; SEQUENCE ANALYSIS, DNA;

EID: 84875737904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060083     Document Type: Article

References (51)

1. American Cancer Society (2012) Cancer Facts and Figures. Atlanta Georgia.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
4. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, et al. (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Medicine 1(3): e65.
5. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P, (2003) Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis. Int J Cancer 107: 797-803.
6. Zeegers MP, Jellema A, Ostrer H, (2003) Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 97: 1894-903.
7. Kicinski M, Vangronsveld J, Nawrot TS, (2011) An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis. PLoS One 6: e27130.
8. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38(6): 652-8.
9. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39(5): 631-7.
10. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39: 645-649.
11. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A103: 14068-73.
12. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39: 638-44.
13. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977-83.
14. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-21.
15. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40: 310-5.
16. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40: 281-3.
17. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 17: 2052-61.
18. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41: 1055-7.
19. Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, et al. (2009) A novel prostate cancer susceptibility locus at 19q13. Cancer Res 69: 2720-3.
20. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 43: 785-91.
21. Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99: 1836-44.
22. Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, et al. (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A 107: 2136-40.
23. Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, et al. (2011) Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Cancer Res 17: 1075-1081.
24. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, et al. (2010) Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2: 62ra92.
25. Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, et al. (2011) Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet 129: 675-85.
26. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, et al. (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358: 910-9.
27. Wiklund FE, Adami HO, Zheng SL, Stattin P, Isaacs WB, et al. (2009) Established prostate cancer susceptibility variants are not associated with disease outcome. Cancer Epidemiol Biomarkers Prev 18: 1659-1662.
28. Witte JS, (2009) Prostate cancer genomics: towards a new understanding. Nat Rev Genet 10: 77-82.
29. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, et al. (2009) Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 18: 1285-9.
30. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, et al. (2011) Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet 7: e1001387.
31. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-7.
32. Vijai J, Kirchhoff T, Gallagher D, Hamel N, Guha S, et al. (2011) Genetic architecture of prostate cancer in the Ashkenazi Jewish population. Br J Cancer 105: 864-9.
33. Wright AF, Carothers AD, Pirastu M, (1999) Population choice in mapping genes for complex diseases. Nat Genet 23: 397-404.
34. Bray SM, Mulle JG, Dodd AF, Pulver AE, Wooding S, et al. (2010) Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A 107: 16222-7.
35. Behar DM, Yunusbayev B, Metspalu M, Metspalu E, Rosset S, et al. (2010) The genome-wide structure of the Jewish people. Nature 466: 238-42.
36. Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, et al. (2010) Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet 86: 850-9.
37. Peltonen L, Palotie A, Lange K, (2000) Use of population isolates for mapping complex traits. Nat Rev Genet 1: 182-90.
38. Agalliu I, Gern R, Leanza S, Burk RD, (2009) Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res 15: 1112-20.
39. Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, et al. (2010) Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. Prostate 70: 1716-27.
40. Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, Volume 1-The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer.
41. Good PI (2005) Permutation, Parametric and Bootstrap Tests of Hypotheses. New York, NY: Springer Science and Business Media.
42. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, et al. (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 21: 289-300.
43. Dubin N, Pasternack BS, (1986) Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 123: 1101-1117.
44. Klienbaum DG, Nizam A, Kupper L, Muller KE (2007) Applied regression analysis and multivariate methods. Pacific Grove, CA: Duxbury Press.
45. Ghosh A, Hartge P, Purdue MP, Chanock SJ, Amundadottir L, et al. (2012) Assessing Disease Risk in Genome-wide Association Studies Using Family History. Epidemiology 23: 616-22.
46. Lindstrom S, Schumacher FR, Cox D, Travis RC, Albanes D, et al. (2012) Common genetic variants in prostate cancer risk prediction-results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 21: 437-44.
47. Xu J, Isaacs SD, Sun J, Li G, Wiley KE, et al. (2008) Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res 14: 5819-24.
48. FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, et al. (2011) Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev 20: 1196-203.
49. Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, et al. (2011) Prostate cancer risk alleles and their associations with other malignancies. Urology 78: 970 e15-20.
50. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-8.
51. Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, et al. (2011) Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 104: 1656-63.